Position in NRIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$22,249,257
+$7,115,647 QoQ
Shares Held
917,117
-6.1% QoQ
Ownership
0.884%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 210 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,364,122 across 562 Biotechnology names. NRIX ranks #70 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in NRIX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,249,257 | 917,117 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $15,133,610 | 976,362 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $8,032,370 | 423,425 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $3,349,925 | 362,546 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $18,099,165 | 1,589,040 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $7,996,986 | 673,147 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,415,128 | 75,113 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,311,398 | 102,866 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,474,409 | 118,563 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,483,447 | 168,942 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $788,467 | 76,402 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,351,935 | 172,002 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $805,663 | 80,647 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $755,759 | 85,108 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,584,435 | 144,302 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $544,536 | 41,791 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $751,850 | 59,341 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $2,083,342 | 148,704 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,875,805 | 99,337 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $17,227 | 575 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $518,210 | 19,533 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,008,620 | 32,442 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||